Franklin-based Echo Therapeutics Raises $5.5M and they are hiring!

Franklin, Mass. -- Echo Therapeutics, a Franklin-based developer of wireless, transdermal continuous glucose monitoring and drug delivery systems, announced on Thursday it has raised about $2.5 million through a series of private placements of the company's stock, and it has received a binding commitment for an additional $3 million. The funding was led by the company's largest shareholder, Platinum Montaur Life Sciences. Current investors and other select institutional and accredited investors also participated in the financings. Echo said it expects to use the net proceeds for product development, clinical studies, working capital and general corporate purposes.

 
http://www.echotx.com/

View Careers at Echo Therapeutics